Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.45 |
| ▸ | MMP8 | P22894 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
| ▸ | XBP1 | P17861 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3960502 | 1.00 | MEN1 (0.49) | MEN1KMT2ACYP1A2CTDSP1MMP8 | |
| SCHEMBL3321160 | 0.86 | CYP1A2 (0.56) | CYP1A2LMNASMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL3321163 | 0.86 | CYP1A2 (0.56) | CYP1A2LMNASMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL3856527 | 0.80 | CYP1A2 (0.53) | KMT2ACYP1A2LMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL1941433 | 0.80 | CYP1A2 (0.53) | KMT2ACYP1A2LMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL1941434 | 0.80 | CYP1A2 (0.53) | KMT2ACYP1A2LMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL3321162 | 0.80 | CYP1A2 (0.56) | CYP1A2LMNASMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL28444789 | 0.77 | MEN1 (0.47) | MEN1KMT2ACYP1A2L3MBTL1SMN1; SMN2 | |
| SCHEMBL24667207 | 0.75 | CYP1A2 (0.47) | MEN1KMT2ACYP1A2LMNASMN1; SMN2 | |
| SCHEMBL27713535 | 0.75 | CYP1A2 (0.47) | MEN1KMT2ACYP1A2LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1386663-B1 | MICROENCAPSULATED METAL CATALYST | JAPAN SCIENCE & TECH AGENCY (JP) | 2009-04-15 | — | — | EP | disclosed |
| US-7488698-B2 | Microencapsulated metal catalyst | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2009-02-10 | — | — | US | disclosed |
| US-20080076662-A1 | Microencapsulated metal catalyst | KOBAYASHI SHU | 2008-03-27 | — | — | US | disclosed |
| US-7307193-B2 | Catalyst containing a Group VIII metal encapsulated in a polymer that has side chains containing an aromatic substituent; stable even in air, easy to recover, and reusable | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2007-12-11 | — | — | US | disclosed |
| US-20040077905-A1 | Microencapsulated metal catalyst | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2004-04-22 | — | — | US | disclosed |
| EP-1386663-A1 | MICROENCAPSULATED METAL CATALYST | Japan Science and Technology Corporation (JP) | 2004-02-04 | — | — | EP | disclosed |
| US-6534657-B2 | Transition metal complexes of chiral phosphine ligands, useful as catalyst in asymmetric reactions, such as hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, isomerization etc. | THE PENN STATE RESEARCH FOUNDATION | 2003-03-18 | — | — | US | disclosed |
| US-20020091280-A1 | Transition metal complexes of chiral phosphine ligands, useful as catalyst in asymmetric reactions, such as hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, isomerization etc. | THE PENN STATE RESEARCH FOUNDATION | 2002-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077905-A1 | Microencapsulated metal catalyst | CHMP4B, LIPA, MGAM | MEN1 1353/4885KMT2A 949/4885CYP1A2 1928/4885 |
| US-20020091280-A1 | Transition metal complexes of chiral phosphine ligands, useful as catalyst in asymmetric reactions, such as hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, isomerization etc. | AGPAT2, AGL, HCK | MEN1 1470/4885KMT2A 1090/4885CYP1A2 870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.